MMP9 and central nervous system cancer: Our increased serum findings are similar to those of the studies by Ramachandran et al., Shehan et al., Xue et al., and Zhou et al. We also found that MMP-9 effectively distinguished between healthy controls and patients with gliomas, with the AUC of 0.852.